Effects of Low Protein Diet Plus α-Ketoacid on Nutritional Status and Renal Interstitial Fibrosis in Adenine-induced Chronic Renal Failure Rats

2008 ◽  
Vol 18 (3) ◽  
pp. S20
Nephron ◽  
1993 ◽  
Vol 64 (1) ◽  
pp. 154-154 ◽  
Author(s):  
H.C. Rayner ◽  
P.R. Burton ◽  
S. Bennett ◽  
J. Walls

2000 ◽  
Vol 11 (4) ◽  
pp. 708-716 ◽  
Author(s):  
MICHEL APARICIO ◽  
PHILIPPE CHAUVEAU ◽  
VALÉRIE DE PRÉCIGOUT ◽  
JEAN-LOUIS BOUCHET ◽  
CATHERINE LASSEUR ◽  
...  

Abstract. Protein-restricted diets are prescribed in patients with chronic renal failure (CRF) to alleviate uremic symptoms and to slow the progression of CRF. The potential deleterious effects of protein restriction on nutritional status and clinical outcome of patients with CRF have raised concern. In this study, data were collected from 1985 to 1998 on 239 consecutive patients (age 50.2 ± 15.6 yr) with advanced CRF (GFR 13.1 ± 4.8 ml/min) to whom a supplemented very low protein diet (SVLPD) providing 0.3 g protein, 35 kcal, and 5 to 7 mg of inorganic phosphorus per kg per day was administered for a mean duration of 29.6 ± 25.1 mo. The diet was supplemented with essential amino acids and ketoanalogs, calcium carbonate, iron, and multivitamins. During SVLPD, protein intake decreased from 0.85 ± 0.23 to 0.43 ± 0.11 g/kg per d, and body mass index and serum albumin concentration remained unchanged overall. Fourteen patients died during SVLPD; death was unrelated to nutritional parameters. Hemodialysis was initiated after SVLPD in 165 patients at a mean GFR of 5.8 ± 1.5 ml/min. During an average of 54 mo on hemodialysis, mortality was low (2.4% after 1 yr) and correlated to age only, not to nutritional parameters observed at the end of SVLPD. Similar results were obtained in 66 transplanted patients (12 were not dialyzed before transplantation). SVLPD can be safely used in patients with CRF without adverse effects on the clinical and nutritional status of the patients. Due to the preservation of nutritional status and the correction of uremic symptoms, the initiation of dialysis was deferred in these patients. The outcome of patients on renal replacement therapy is not affected by prior treatment with SVLPD during the predialysis phase of CRF.


Nephron ◽  
1998 ◽  
Vol 79 (2) ◽  
pp. 173-180 ◽  
Author(s):  
N. Soroka ◽  
D.S. Silverberg ◽  
M. Greemland ◽  
Y. Birk ◽  
M. Blum ◽  
...  

1995 ◽  
Vol 6 (5) ◽  
pp. 1379-1385
Author(s):  
J Coresh ◽  
M Walser ◽  
S Hill

Concerns have been raised about the possibility of protein restriction resulting in malnutrition and poor subsequent survival on dialysis. However, no studies have examined patients treated with protein restriction to determine their subsequent survival on dialysis. This study prospectively monitored 67 patients with established chronic renal failure (mean initial serum creatinine of 4.3 mg/dL) who were treated with a very low-protein diet (0.3 g/kg per day) supplemented with either essential amino acids or a ketoacid-amino acid mixture and observed closely for clinical complications. Forty-four patients required dialysis. Once dialysis was started, dietary treatment was no longer prescribed. The cumulative mortality rate during the first 2 yr after starting dialysis was 7% (95% confidence interval, 0 to 16%). During this period, only two deaths occurred compared with 11.5 deaths expected on the basis of national mortality rates adjusted for age, sex, race, and cause of renal disease (P = 0.002). However, the protective effect was limited to the first 2 yr on dialysis. Thereafter, mortality rates increased, resulting in a total of 10 deaths during 96.4 person-years of follow-up, which was not significantly lower than the 14.9 deaths expected (P = 0.25). Extrapolation of sequential serum creatinine measurements made before dietary treatment suggests that the improved survival cannot be due to the early initiation of dialysis. Although the lack of an internal control group and data on dialysis lends uncertainty, the large difference in mortality rate between these patients and the nationwide experience indicates that protein restriction and close clinical monitoring predialysis does not worsen and may substantially improve survival during the first 2 yr on dialysis. These findings point out the importance of studying predialysis treatments as a means for lowering mortality on dialysis.


1991 ◽  
Vol 5 (4) ◽  
pp. 496-500 ◽  
Author(s):  
Anne-Margret Wingen ◽  
Claudia Fabian-Bach ◽  
Otto Mehls

The Lancet ◽  
1991 ◽  
Vol 338 (8764) ◽  
pp. 442-444 ◽  
Author(s):  
Giuliano Barsotti ◽  
Sergio Giovannetti ◽  
N. Gretz ◽  
M. Strauch ◽  
Francesco Locatelli ◽  
...  

2000 ◽  
Vol 36 (6) ◽  
pp. 1201-1206 ◽  
Author(s):  
Valérie de Précigout ◽  
Philippe Chauveau ◽  
Caroline Delclaux ◽  
Wael El Haggan ◽  
Laurence Baillet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document